SEP 11, 2020 9:51 PM PDT

Study Reveals Tumor Defense Mechanism... And How to Beat It

WRITTEN BY: Amanda Mikyska

Video:  Related studypublished at about the same time as Wechsler-Reya et. al.  Explains the hedgehog pathway, which P53 is located on.

P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pauses cell growth/division to verify that growth is necessary and that no mistakes were made in the process.  Without this gene, cells can grow and divide uncontrolled, resulting in tumor cells.  However, previous research shows that addressing P53 alone does not completely stop tumor growth.

In a new study, researchers at Sanford Burnham Prebys Medical Discovery Institute show that medulloblastoma, a brain cancer that affects children, deactivates P53 which deactivates other genes downstream.  One of those genes produces major histocompatibility complex (MHC-I) proteins which are tagged onto cells to label them as cancerous.  The immune system recognizes the MHC-I protein and destroys the cancerous cell.  When MHC-I is deactivated, the immune system never receives a help signal, and the tumor can grow undetected.

Tumor necrosis factor (TNF) increases the production of MHC-I to overcome the cancer’s defense by labeling all tumor cells.  The study, conducted in mice, showed that TNF was able to activate enough MHC-I to alert the immune system of the problem.  Once the immune system is alert, T-cells kill the tumor.

Medulloblastoma requires an aggressive combination of surgery, chemotherapy, and radiation.  On developing brains, this often results in chronic side effects like hormone imbalances, intellectual disabilities, and a predisposition to more cancer.  Immunotherapy is a hopeful line of research for a more effective treatment with fewer and less severe side effects.  

 

Sources:  Sanford Burnham Prebys Medical Discovery Institute via EurekAlert!, Scheidt et. al, Wechsler-Reya et. al

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
JUN 11, 2021
Cannabis Sciences
Does Cannabis Interact with the COVID Vaccine?
JUN 11, 2021
Does Cannabis Interact with the COVID Vaccine?
As of June 10th 2021, 43% of people in the US aged 12 and over have been fully vaccinated for COVID-19, with 5 ...
JUN 29, 2021
Immunology
The Heartbreaking Nature of COVID Revealed
JUN 29, 2021
The Heartbreaking Nature of COVID Revealed
Researchers at the Washington University School are getting to the root of heart damage resulting from COVID-19 infectio ...
JUL 26, 2021
Cell & Molecular Biology
Cells Have a Self-Defense Mechanism Against Bacteria
JUL 26, 2021
Cells Have a Self-Defense Mechanism Against Bacteria
There are natural detergents that cells can use to defend themselves from pathogens. Scientists have now identified a pr ...
AUG 19, 2021
Immunology
Immune Enzyme Kills Viruses but Makes Tumors Stronger
AUG 19, 2021
Immune Enzyme Kills Viruses but Makes Tumors Stronger
Robert Louis Stevenson’s 1886 novel Strange Case of Dr. Jekyll and Mr. Hyde describes a man who is a kind, respect ...
AUG 31, 2021
Immunology
Convalescent Plasma Therapy for COVID-19 Doesn't Work
AUG 31, 2021
Convalescent Plasma Therapy for COVID-19 Doesn't Work
After encountering an infectious agent, the immune system begins churning out antibodies—Y-shaped warriors that ne ...
SEP 24, 2021
Drug Discovery & Development
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
SEP 24, 2021
WHO Recommends Antibody Treatment for High Risk COVID-19 Patients
The World Health Organization (WHO) has recommended a combination of two antibody treatments for patients at risk of adv ...
Loading Comments...